Valuation: GI Innovation, Inc.

Market Cap 59TCr 44Cr 39Cr 36Cr 33Cr 62Cr 4.21TCr 63Cr 436.25Cr 169.68Cr 2.15TCr 164.12Cr 160.6Cr 6.91TCr P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 55TCr 41Cr 37Cr 34Cr 31Cr 58Cr 3.97TCr 59Cr 410.44Cr 159.64Cr 2.02TCr 154.41Cr 151.1Cr 6.5TCr EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.32%
Yield 2024 *
-
Yield 2025 -
1 day+2.83%
1 week+5.71%
Current month+14.09%
1 month+12.11%
3 months+0.89%
6 months-27.61%
Current year-48.58%
1 week 7,740
Extreme 7740
9,740
1 month 7,740
Extreme 7740
9,800
Current year 6,470
Extreme 6470
18,830
1 year 6,470
Extreme 6470
20,950
3 years 6,470
Extreme 6470
24,900
5 years 6,470
Extreme 6470
24,900
10 years 6,470
Extreme 6470
24,900
Manager TitleAgeSince
Chief Executive Officer 58 02/07/2025
Chief Executive Officer 54 16/06/2021
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Director/Board Member 54 16/06/2021
Director/Board Member 58 01/07/2017
Director/Board Member 64 01/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
20/01/26 Expiration 14 0.0000% -
20/01/26 Exercice

Chief Technology Officer

445 0.0007%
20/01/26 Exercice 14 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.83%+5.71%-52.51%-26.23% 42Cr
+4.16%+3.42%+49.37%+94.17% 7.43TCr
+2.76%-1.60%+22.80%+78.53% 5.7TCr
+0.24%-1.34%+3.41%+34.31% 4.83TCr
-3.76%-2.36%+328.64%+697.36% 4.45TCr
-2.30%-3.25%+26.94%+31.02% 4.38TCr
+0.31%-0.72%+5.25%+108.55% 4.11TCr
-0.11%+2.30%+9.19%+58.68% 3.11TCr
+4.51%+8.43%+37.27%+34.97% 2.9TCr
-1.96%-2.84%-8.93%-13.88% 2.45TCr
Average +0.67%+1.20%+42.14%+109.75% 3.94TCr
Weighted average by Cap. +0.77%-0.48%+56.55%+133.19%

Financials

2024 2025
Net sales 2.43Cr 18.14T 16.11T 15.07T 13.66T 25.8T 17.49L 25.99T 2L 70.41T 9L 68.1T 66.64T 28.68L 583.81Cr 43.62L 38.72L 36.24L 32.85L 62.03L 42Cr 62.48L 4.35Cr 1.69Cr 21Cr 1.64Cr 1.6Cr 69Cr
Net income -5.88TCr -4.39Cr -3.9Cr -3.65Cr -3.31Cr -6.25Cr -423.43Cr -6.29Cr -44Cr -17Cr -216.01Cr -16Cr -16Cr -694.42Cr -3.51TCr -2.63Cr -2.33Cr -2.18Cr -1.98Cr -3.73Cr -253.08Cr -3.76Cr -26Cr -10Cr -129.11Cr -9.85Cr -9.64Cr -415.05Cr
Net Debt -343.96Cr -25.7L -22.82L -21.35L -19.35L -36.55L -25Cr -36.81L -2.56Cr -99.74L -13Cr -96.47L -94.4L -41Cr -3.46TCr -2.59Cr -2.3Cr -2.15Cr -1.95Cr -3.68Cr -249.42Cr -3.71Cr -26Cr -10Cr -127.24Cr -9.71Cr -9.5Cr -409.05Cr
Projected Income Statement - Annual - GI Innovation, Inc.
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
06/26/06 ₩9,070.00 +2.83% 2,45,535
02/26/02 ₩8,820.00 -7.55% 4,13,299
01/26/01 ₩9,540.00 +20.00% 6,49,090
30/26/30 ₩7,950.00 -0.25% 1,89,702
29/26/29 ₩7,970.00 -7.11% 3,84,299
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock